Credo Brands Marketing Limited (CBLM) is a leading marketing, sales, and distribution company in India. The company was founded in 2005 by Saurabh Agarwal and Amit Agarwal. CBLM has a strong presence in the FMCG, healthcare, and consumer durables sectors. The company has a team of over 1,000 employees and operates from 10 offices across India.
| Metric | FY20 | FY21 |
| Revenue | Rs. 1,100 crore | Rs. 1,400 crore |
| Net Profit | Rs. 120 crore | Rs. 140 crore |
| Number of Employees | 1,000 | 1,200 |
| Offices | 10 | 12 |
CBLM is a public company and its shares are listed on the BSE and the NSE. The company’s IPO was opened on February 25, 2023, and closed on March 1, 2023. The IPO was subscribed 11.5 times, with a total issue size of Rs. 1,000 crore.
The proceeds from the IPO will be used to fund CBLM’s growth plans, including expanding its distribution network and investing in new product development and acquisitions.
CBLM is a profitable company and has been growing rapidly in recent years. The company’s revenue grew from Rs. 1,100 crore in FY20 to Rs. 1,400 crore in FY21. CBLM’s net profit grew from Rs. 120 crore in FY20 to Rs. 140 crore in FY21.
CBLM is a well-managed company with a strong track record of growth. The company is well-positioned to continue to grow in the future.
The IPO of CBLM is a good opportunity for investors to gain exposure to a growing company in the Indian FMCG, healthcare, and consumer durables sectors. The company has a strong management team and a proven track record of success. The IPO is well-priced and the company is expected to continue to grow in the future.
For those seeking an investment opportunity in a rapidly growing Indian FMCG, healthcare, and consumer durables company, CBLM’s IPO is an excellent choice.
As an investor, I would be interested in the IPO of Credo Brands Marketing Limited (CBLM). The company has a strong track record of growth, with revenue and net profit increasing significantly in recent years. It is well-managed and has a good reputation in the industry. The IPO is well-priced, and I believe that the company is poised for continued growth in the future.
I would also be interested in the IPO of Yatharth Hospital. The company is a leading provider of healthcare services in India, and it has been growing rapidly in recent years. The IPO offers a good opportunity to invest in a high-quality healthcare company.